Cardiovascular Devices; Reclassification of External Pacemaker   Pulse Generator Devices; Reclassification of Pacing System Analyzers. Final order.
The Food and Drug Administration (FDA) is issuing a final order to reclassify external pacemaker pulse generator (EPPG) devices, which are currently preamendments class III devices (regulated under product code DTE), into class II (special controls) and to reclassify pacing system analyzers (PSAs) into class II (special controls) based on new information and subject to premarket notification. This final order also creates a separate classification regulation for PSAs and places single and dual chamber PSAs, which are currently classified with EPPG devices, and triple chamber PSAs (TCPSAs), which are currently postamendments class III devices, into that new classification regulation.
D058409:Cardiac Resynchronization Therapy Devices / Q000145:classification*; D018795:Device Approval / Q000331:legislation & jurisprudence; D004869:Equipment Safety / Q000145:classification; D006801:Humans; D010138:Pacemaker, Artificial / Q000145:classification*; D014481:United States